Local organizations fighting to end the spread of AIDS by 2030 will be a focal point at UAB’s World AIDS Day celebration.
Protecting vulnerable populations from contracting influenza is a priority among UAB and local organizations.
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
This more comprehensive approach may be needed to find ways to delay the progressive heart failure.
Sarah-Jeanne Salvy, Ph.D., says the findings of her research emphasize the importance of considering social factors when examining the impact of neighborhood on physical activity.
The center is funded by a $7 million grant from the National Institute on Minority Health and Health Disparities.
Inhibition of this microRNA might improve response to newer diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta.
A collaboration between Birmingham AIDS Outreach and the UAB 1917 Clinic looks to provide nutrition support and education to address and prevent the rise of chronic disease in patients living with HIV.
A two-drug combination therapy for cystic fibrosis is shown to be effective. Triple combination therapy is close behind.
Do you know the warning signs of sepsis? Most Americans don’t … and they should.
Page 3 of 38